144 related articles for article (PubMed ID: 30183692)
1. The Impact of Multiple Primary Rules on Cancer Statistics in Canada, 1992 to 2012.
Zakaria D; Shaw A
J Registry Manag; 2018; 45(1):8-20. PubMed ID: 30183692
[TBL] [Abstract][Full Text] [Related]
2. The effect of multiple primary rules on cancer incidence rates and trends.
Weir HK; Johnson CJ; Ward KC; Coleman MP
Cancer Causes Control; 2016 Mar; 27(3):377-90. PubMed ID: 26809509
[TBL] [Abstract][Full Text] [Related]
3. Childhood cancer incidence in Canada: demographic and geographic variation of temporal trends (1992-2010).
Xie L; Onysko J; Morrison H
Health Promot Chronic Dis Prev Can; 2018 Mar; 38(3):79-115. PubMed ID: 29537768
[TBL] [Abstract][Full Text] [Related]
4. Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015.
Zakaria D; Shaw A; Woods R; De P; Davis F
J Registry Manag; 2018; 45(1):117-131. PubMed ID: 31017881
[TBL] [Abstract][Full Text] [Related]
5. Variation in breast cancer counts using SEER and IARC multiple primary coding rules.
Hotes JL; Ellison LF; Howe HL; Friesen I; Kohler B
Cancer Causes Control; 2004 Mar; 15(2):185-91. PubMed ID: 15017131
[TBL] [Abstract][Full Text] [Related]
6. The effect of multiple primary rules on population-based cancer survival.
Weir HK; Johnson CJ; Thompson TD
Cancer Causes Control; 2013 Jun; 24(6):1231-42. PubMed ID: 23558444
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
8. Projected estimates of cancer in Canada in 2024.
Brenner DR; Gillis J; Demers AA; Ellison LF; Billette JM; Zhang SX; Liu JL; Woods RR; Finley C; Fitzgerald N; Saint-Jacques N; Shack L; Turner D;
CMAJ; 2024 May; 196(18):E615-E623. PubMed ID: 38740416
[TBL] [Abstract][Full Text] [Related]
9. Changing trends in thyroid cancer incidence in Canada: A histologic examination, 1992 to 2016.
Ellison LF; Bushnik T
Health Rep; 2020 Jan; 31(1):15-25. PubMed ID: 31940149
[TBL] [Abstract][Full Text] [Related]
10. Incidence Trends of Lip, Oral Cavity, and Pharyngeal Cancers: Global Burden of Disease 1990-2017.
Du M; Nair R; Jamieson L; Liu Z; Bi P
J Dent Res; 2020 Feb; 99(2):143-151. PubMed ID: 31874128
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in incidence rates for selected alcohol-related cancers in the United States.
Polednak AP
Alcohol Alcohol; 2005; 40(3):234-8. PubMed ID: 15797879
[TBL] [Abstract][Full Text] [Related]
12. Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).
Webster AC; Supramaniam R; O'Connell DL; Chapman JR; Craig JC
Nephrology (Carlton); 2010 Jun; 15(4):491-501. PubMed ID: 20609104
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
14. Joinpoint Regression Analysis of Trends in Multiple Sclerosis Incidence in Kuwait: 1980-2019.
Akhtar S; Al-Abkal J; Alroughani R
Neuroepidemiology; 2020; 54(6):472-481. PubMed ID: 33176327
[TBL] [Abstract][Full Text] [Related]
15. Explaining geographic variation in breast and cervical cancer incidence rates in US Hispanic women.
Polednak AP
Ethn Dis; 2005; 15(4):727-32. PubMed ID: 16259500
[TBL] [Abstract][Full Text] [Related]
16. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
18. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
19. Italian cancer figures--report 2006: 1. Incidence, mortality and estimates.
AIRT Working Group
Epidemiol Prev; 2006; 30(1 Suppl 2):8-10, 12-28, 30-101 passim. PubMed ID: 16826725
[TBL] [Abstract][Full Text] [Related]
20. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
